Question 1

What’s the financial overview for Seres Therapeutics, Inc.?

Accepted Answer

Seres Therapeutics, Inc.’s market cap stands at $0.00 trillion right now. The company’s trailing twelve-month earnings per share EPS is $-7.95, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Seres Therapeutics, Inc. Stock ROE tell us?

Accepted Answer

Seres Therapeutics, Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for Seres Therapeutics, Inc.?

Accepted Answer

The Seres Therapeutics, Inc. stock per share price is $12.57.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$0.00	$0.00	$1.42M	$1.56M
Gross Profit	$0.00	$0.00	-$1.42M	-$1.56M
Gross Profit Ratio	$0.00
R&D Expenses	$12.84M	$16.46M	$17.88M	$21.70M
SG&A Expenses	$12.46M	$12.71M	$16.06M	$13.91M
Operating Expenses	$28.84M	$29.17M	$32.51M	$35.61M
Total Costs & Expenses	$28.84M	$29.17M	$31.34M	$37.17M
Interest Income	$437000.00	$652000.00	$1.23M	$1.65M
Interest Expense	$0.00	$0.00	$3.45M	$4.66M
Depreciation & Amortization	$3.09M	$1.40M	$1.42M	$1.56M
EBITDA	-$12.54M	-$49.63M	-$28.003M	-$33.91M
EBITDA Ratio
Operating Income	-$28.84M	-$29.17M	-$31.34M	-$37.17M
Operating Income Ratio
Other Income/Expenses (Net)	$13.20M	-$21.86M	-$1.52M	-$2.96M
Income Before Tax	-$15.64M	-$51.03M	-$32.87M	-$40.13M
Income Before Tax Ratio
Income Tax Expense	$0.00	$0.00	$0.00	$1.52M
Net Income	-$15.64M	$88.78M	-$32.87M	-$40.13M
Net Income Ratio
EPS	-$0.10	$0.58	-$0.22	-$0.27
Diluted EPS	-$0.10	$0.58	-$0.22	-$0.27
Weighted Avg Shares Outstanding	$8.65M	$152.65M	$151.51M	$146.10M
Weighted Avg Shares Outstanding (Diluted)	$8.65M	$152.65M	$151.51M	$146.10M

Seres Therapeutics, Inc.